Gastritis, Chronic, Erosive
Gastritis, Chronic, Erosive
National Organization for Rare Disorders, Inc.
It is possible that the main title of the report Gastritis, Chronic, Erosive is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
Related Disorders List
Information on the following diseases can be found in the Related Disorders section of this report:
- Crohn's Disease
- Acute Gastritis
- Peptic Ulcer
- Zollinger-Ellison Syndrome
Chronic, Erosive Gastritis is characterized by many inflamed lesions in the mucous lining of the stomach. It may be a transitory or a chronic condition lasting for years.
Chronic, Erosive Gastritis is an inflammation of the stomach characterized by multiple lesions in the mucous lining causing ulcer-like symptoms. These symptoms may include a burning and heavy feeling in the pit of the stomach, mild nausea, vomiting, loss of appetite and weakness. In severe cases there can be bleeding of the stomach which may result in anemia. Some people with this disorder, especially chronic aspirin users, may show no apparent symptoms until the disease has advanced. An accurate diagnosis can be made by physician's visual inspection of the stomach using a gastroscope.
The exact cause of Chronic, Erosive Gastritis is unknown. It may be the result of an infection, over indulgence of alcohol, or persistent use of aspirin or non-steroidal anti-inflammatory medications such as ibuprofen. Stress tends to make symptoms worse. Crohn's disease and Sarcoidosis have been known to be factors in some cases of Chronic, Erosive Gastritis, while some cases have no apparent cause at all.
Chronic, Erosive Gastritis usually occurs during middle age and is more common in males than females. Alcoholics and chronic aspirin or ibuprofen users (e.g. people with arthritis) are more susceptible to this disorder.
The following disorders may have symptoms similar to Chronic, Erosive Gastritis. Comparisons may be useful for a differential diagnosis:
Crohn's Disease, also known as ileitis, regional enteritis, or granulomatous colitis is a form of inflammatory bowel disease characterized by severe, often granulomatous, chronic inflammation of the wall of the gastrointestinal tract. In most cases, a segment of the intestines called the ileum. Crohn's disease can be difficult to manage. Mortality due to the disease itself, or to complications from the disease, is low. (For more information on this disorder, choose "Crohn's" as your search term in the Rare Disease Database.)
Acute Erosive Gastritis is an inflammation of the stomach characterized by lesions in the mucous membranes of the stomach and ulcer-like symptoms. This type of Gastritis is caused by a variety of stresses such as major trauma, multiple injuries or serious burns.
Peptic Ulcer is a common disorder usually characterized by a single lesion of the mucous membranes of the esophagus, stomach or duodenum. These lesions may be caused by an over secretion of acid or pepsin and are characterized by pain, heartburn, nausea and vomiting.
Zollinger-Ellison Syndrome is a rare condition characterized by stomach ulcers and small tumors (usually of the pancreas) which secrete a hormone that produces excessive amounts of gastric juices in the stomach. These tumors can also appear in the lower stomach wall, spleen or lymph nodes close to the stomach. Large amounts of gastric acid can be found in lower stomach areas where ulcers can form. Ulcers can appear suddenly even in areas where they are rarely found, may persist following treatment, and can be accompanied by diarrhea. Prompt medical treatment of these ulcers is necessary to prevent complications such as bleeding and perforation. (For more information on this disorder, choose "Zollinger-Ellison" as your search term in the Rare Disease Database.)
Because Chronic, Erosive Gastritis may cause symptoms similar to other gastrointestinal disorders, a full medical history must be known before an effective treatment can be determined. Most cases are usually treated with acid neutralizing medications (antacids) and H2 blocker drugs such as Zantac (ranitidine) or Tagamet (cimetidine). Dietary changes and avoiding the irritating causes such as stomach irritating drugs or stressful situations are also helpful in eliminating the symptoms of Chronic, Erosive Gastritis.
The prostaglandin E1 analog drug, Cytotec (misoprostol) has proven to be an effective preventative medication for gastric lesions associated with high-dose aspirin or ibuprofen therapy. This drug is effective in healing the gastric mucosal lesions without altering the therapeutic benefits of the non-steroidal anti-inflammatory drugs given to arthritis patients. Misoprostol can have severe effects on a developing fetus and must be administered with extreme caution. Other treatment is symptomatic and supportive.
At the present time, a study is being conducted on the effectiveness of the drug bismuthsubsalicylate as a treatment for Chronic, Erosive Gastritis. More research must be conducted to determine long-term safety and effectiveness of this drug.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
Internal Medicine, 2nd Ed.: Jay H. Stein, ed-in-chief; Little, Brown and Co., 1987. Pp. 110.
The Merck Manual, 15th Ed.: Robert Berkow, M.D. ed-in-chief; Merck, Sharp & Dohme Laboratories., 1987. Pp. 736.
Treatment of Chronic Erosive Gastritis with Prednisolone. M. Farthing et al.; Gut (Sept 1981; 22(9)). Pp. 759-62.
Mechanisms of Non-Steroidal Anti-Inflammatory Drug-Induced Gastric Damage. R. Schoen et al.; Am J Med (Apr 1989; 86(4)). Pp. 449-558.
Neoplasia in Chronic Erosive (Valioliform) Gastritis. M. Cappell et al.; Dig Dis Sci (Aug 1988; 33(8)). Pp. 1035-39.
Misoprostol Heals Gastroduodenal Injury in Patients with Rheumatoid Arthritis Receiving Aspirin. S. Roth et al.; Arch Intern Med (Apr 1989; 149(4)). Pp. 775-79.
Prostaglandin E1 Analogue Therapy in the Treatment of Refractory Gastric Ulcer in an Elderly Patient. E. Ramsey et al.; Arch Intern Med (Oct 1988; 148(10)). Pp. 2275-76.
Chronic Erosive Gastritis: A Clinical Study. C. Gallagher et al.; Am J Gastroenterol (Apr 1987; 82(4)). Pp. 302-06.
Chronic Erosive Gastritis - A Recently Recognized Disorder. G. Elta et al.; Dig Dis Sci (Jan 1983; 28(1)). Pp. 7-12.
FROM THE INTERNET
eMedicine - Gastritis, Acute : Article by Mohammad Wehbi, MD
Crohn's and Colitis Foundation of America
386 Park Avenue South
New York, NY 10016-7374
Digestive Disease National Coalition
507 Capitol Court, NE
Washington, DC 20002
NIH/National Institute of Diabetes, Digestive & Kidney Diseases
Office of Communications & Public Liaison
Bldg 31, Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560
Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
3 St. Andrews Place
London, NW1 4LB
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into myCigna.com. For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email firstname.lastname@example.org
Last Updated: 9/10/2007
Copyright 1989, 1998, 2007 National Organization for Rare Disorders, Inc.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.